These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21337312)

  • 41. [Calcific uremic arteriolopathy: clinical features and treatment].
    Kudumija B; Knotek M; Pavlović D; Dits S
    Lijec Vjesn; 2015; 137(3-4):91-5. PubMed ID: 26065286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Sodium thiosulfate--new hope for the treatment of calciphylaxis].
    Heiro M; Mäkelä L; Koivuviita N; Manner I; Tertti R; Hohenthal U; Metsärinne K
    Duodecim; 2011; 127(16):1690-6. PubMed ID: 21972587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Calcific uremic arteriolopathy in hemodialysis patient, review of literature through five cases reports].
    Chettati M; Adnouni A; Fadili W; Laouad I
    Nephrol Ther; 2018 Nov; 14(6):439-445. PubMed ID: 30401462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Early diagnosis, prevention and treatment for calcific uremic arteriolopathy].
    Zhou Y; Zhang H; Sun J; Ji Y; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 43(11):1251-1256. PubMed ID: 30643072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A case report comparing various radiological tests in the diagnosis of calcific uremic arteriolopathy.
    Bleibel W; Hazar B; Herman R
    Am J Kidney Dis; 2006 Oct; 48(4):659-61. PubMed ID: 16997063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study.
    Gaisne R; Péré M; Menoyo V; Hourmant M; Larmet-Burgeot D
    BMC Nephrol; 2020 Feb; 21(1):63. PubMed ID: 32101140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful treatment of extensive uremic calciphylaxis with intravenous sodium thiosulfate and its potential in treating various diseases of pathologic calcification.
    Burja S; Jovic A; Ekart R; Piko N; Miljkovic J; Breznik V
    Acta Dermatovenerol Alp Pannonica Adriat; 2019 Mar; 28(1):37-40. PubMed ID: 30901068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients.
    Zitt E; König M; Vychytil A; Auinger M; Wallner M; Lingenhel G; Schilcher G; Rudnicki M; Salmhofer H; Lhotta K
    Nephrol Dial Transplant; 2013 May; 28(5):1232-40. PubMed ID: 23291368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutaneous necrosis from calcific uremic arteriolopathy.
    Coates T; Kirkland GS; Dymock RB; Murphy BF; Brealey JK; Mathew TH; Disney AP
    Am J Kidney Dis; 1998 Sep; 32(3):384-91. PubMed ID: 9740153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral sodium thiosulfate as maintenance therapy for calcific uremic arteriolopathy: a case series.
    AlBugami MM; Wilson JA; Clarke JR; Soroka SD
    Am J Nephrol; 2013; 37(2):104-9. PubMed ID: 23363879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unexpectedly severe metabolic acidosis associated with sodium thiosulfate therapy in a patient with calcific uremic arteriolopathy.
    Selk N; Rodby RA
    Semin Dial; 2011; 24(1):85-8. PubMed ID: 21338397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful treatment of calcific uraemic arteriolopathy with bisphosphonates.
    Torregrosa JV; Durán CE; Barros X; Blasco M; Arias M; Cases A; Campistol JM
    Nefrologia; 2012 May; 32(3):329-34. PubMed ID: 22592420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multifaceted approach to a rare clinical case of calciphylaxis in a renal transplant recipient.
    Massimetti C; Bellasi A; Modoni A; Gomes V; Feriozzi S
    G Ital Nefrol; 2019 Sep; 36(5):. PubMed ID: 31580546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-uremic calciphylaxis in a patient with multiple rheumatologic diseases.
    Kusari A; Cotter D; Hinds B; Paravar T
    Dermatol Online J; 2019 Feb; 25(2):. PubMed ID: 30865406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients.
    Peng T; Zhuo L; Wang Y; Jun M; Li G; Wang L; Hong D
    Nephrology (Carlton); 2018 Jul; 23(7):669-675. PubMed ID: 28603903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early stages of calciphylaxis: are skin biopsies the answer?
    Latus J; Kimmel M; Ott G; Ting E; Alscher MD; Braun N
    Case Rep Dermatol; 2011 Sep; 3(3):201-5. PubMed ID: 22110432
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults.
    Araya CE; Fennell RS; Neiberger RE; Dharnidharka VR
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1161-6. PubMed ID: 17699342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraperitoneal sodium thiosulfate for the treatment of calciphylaxis.
    Mataic D; Bastani B
    Ren Fail; 2006; 28(4):361-3. PubMed ID: 16771254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calciphylaxis and sodium thiosulphate: a glimmer of hope in desperate situation.
    Burnie R; Smail S; Javaid MM
    J Ren Care; 2013 Jun; 39(2):71-6. PubMed ID: 23551819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calciphylaxis and its diagnosis: A review.
    Baby D; Upadhyay M; Joseph MD; Asopa SJ; Choudhury BK; Rajguru JP; Gupta S
    J Family Med Prim Care; 2019 Sep; 8(9):2763-2767. PubMed ID: 31681640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.